Visceral leishmaniasis (Kala-azar) in solid organ transplantation: Report of five cases and review

Clinical Infectious Diseases

Volumn 29, Issue 4, 1999, Pages 918-921

  Hernandez Perez J ^a   Yebra Bango, M ^a   Jimenez Martinez E ^a   Sanz Moreno, C ^a   Cuervas Mons, V ^a   Alonso Pulpon L ^a   Ramos Martinez A ^a   Fernandez Fernandez J ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; AZATHIOPRINE; CIPROFLOXACIN; KETOCONAZOLE; MEGLUMINE ANTIMONATE; METRONIDAZOLE; PAROMOMYCIN; PREDNISONE; STIBOGLUCONATE SODIUM;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LEISHMANIA DONOVANI; LIVER TRANSPLANTATION; MALE; MEDICAL LITERATURE; MORTALITY; PRIORITY JOURNAL; RECURRENT INFECTION; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

EID: 0343619356     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520457     Document Type: Article

References (32)

1. Rubin RH. Infection in the renal transplant recipient. Am J Med 1981;70: 405-10.
2. Pearson RD, Sousa AQ. Clinical spectrum of leishmaniasis. Clin Infect Dis 1996;22:1-3.
3. Badaró R, Carvalho EM, Rocha H, Qucìroz AC, Jones TC. Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet 1986;22:647.
4. Montalbán C, Martínez-Fernández R, Calleja JL, et al. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev Infect Dis 1989;11: 655-60.
5. Guerrero ML, Aguado JM, Buzón L, Barros C, Martín T, Bouza E. Visceral leishmaniasis in immunocompromised hosts. Am J Med 1987; 83:1098-102.
6. Salvá M, Fernández Fernández J, Berisa F, et al. Visceral leishmaniasis in kidney transplantation: report of one case. In: Terasaki PI, ed. Clinical kidney transplants 1986. Los Angeles: VCLA Tissue Typing Laboratory, 1986:134.
7. Ma DDF, Concannon AJ, Hayes J. Fatal leishmaniasis in a renal-transplant patient. Lancet 1979;2:311-2.
8. Broeckaert-van Orshoven A, Michielsen P, Vandepitte J. Fatal leishmaniasis in renal-transplant patients. Lancet 1979;2:740-1.
9. Lamas S, Orte L, Parras F, García J, Matesanz R, Ortuño J. Non-fatal leishmaniasis in a renal transplant recipient. Nephron 1987;45:71.
10. Le Cacheux P, Hurault de Ligny B, Reman O, Ryckelynck JP. Leishmaniose viscérale d'évolution favorable chez une transplante rénale. Rev Med Interne 1990;11:250-1.
11. Donovan KL, White AD, Cooke DA, Fisher DJ. Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant recipient. J Infect 1990;21:107-10.
12. Kher V, Ghosh AK, Gupta A, Arora P, Dhole TN. Visceral leishmaniasis: an unusual case of fever in a renal transplant recipient. Nephrol Dial Transplant 1991;6:736-8.
13. Rousaud F, Solá R, Oliver A, Ayats R, del Rio G, Recaida de leishmaniasis visceral (LV) tras terapia inmunosupresora antirrechazo en un paciente trasplantado de rirnon. Buena evolución a largo plazo. Nefrología 1991; 11(1):72-4.
14. Moulin B, Ollier J, Bouchoauareb D, Purgus R, Olmer M. Leishmaniasis: a rare cause of unexplained fever in a renal graft recipient. Nephron 1992;60:360-2.
15. Orofino L., Marcen R, Gamez C, et al. Visceral leishmaniasis in renal transplant patients. Nephrol Dial Transplant 1992;7:651-5.
16. Halim MA, Alfurayh O, Kalin ME, Dammas S, al-Eisa A, Damanhouri G. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate. Clin Infect Dis 1993;16:397-9.
17. Jokipii L, Salmela K, Saha H, et al. Leishmaniasis diagnosed from bron-choalveolar lavage. Scand J Infect Dis 1992;24:677-81.
18. Portolés J, Prats D, Torralbo A, Herrero JA, Torrente J, Barrientos A. Visceral leishmaniasis: a cause of opportunistic infection in renal transplant patients in endemic areas. Transplantation 1994;57:1677-9.
19. Moroni G, Bossi L. Don't forget visceral leishmaniasis in transplant patients. Nephrol Dial Transplant 1995;10:563-4.
20. Mittal R, Saxena S, Guleria S, et al. Visceral leishmaniasis: a rare cause of unexplained pyrexia in a renal allograft recipient. Nephron 1995;70: 123-4.
21. Malek Hosseini SA, Javid R, Salahi H, Nezakatgoo N, Ahmad E, Ghahramani N. A case of kala-azar in a kidney transplant patient. Transplant Proc 1995:27:2715.
22. Sharma RK, Jha R, Kumar P, et al. Visceral leishmaniasis in a renal transplant recipient: diagnostic and therapeutic problems. Am J Nephrol 1996;16:358-60.
23. Esteban RJ, Bravo JA, Osuna A, Asensio C. Early antimoniate poisoning in a non-fatal visceral leishmaniasis kidney transplant recipient with renal failure. Nephrol Dial Transplant 1996;11:1898.
24. Apaydin S, Ataman R, Serdengect K. et al. Visceral Ieishmaniasis without fever in a kidney transplant recipient. Nephron 1997;75:241-2.
25. Berenguer J, Gómez-Campderá F, Padilla B, et al. Visceral leishmaniasis (kala-azar) in transplant recipients. Transplantation 1998;65: 1401-4.
26. Torregrosa JV, Ricart MJ, Montesinos M, et al. Visceral leishmaniasis-like cause of unexplained fever in a reno-pancreatic graft recipient. Nephron 1993;65:318-9.
27. Horber FF, Lerut JP, Reichen J, Zimmermann A, Jaeger P, Malinverni R. Visceral leishmaniasis after orthotopic liver transplantation: impact of persistent splenomegaly. Transpl Int 1993;6:55-7.
28. Ramos A, Portero JL, Gazapo T, Yebra M, Portero F, Martin T. Leishmaniasis visceral en pacientes inmunodeprimidos. An Med Interna 1998;15;301-4.
29. Peters B, Fish D, Golden R. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Q J Med 1990;77: 1101-11.
30. Ribera E, Ocaña I, Otero J, Cortés E, Gasser I, Pahissa A. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. Am J Med 1996;100:496 501.
31. Angarano G, Maggi P, Coppola SL, Cavaliere RL. Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients. Fur J Clin Microbiol Infect Dis 1998;17:365-7.
32. Seaman J, Boer C, Wilkinson R, et al. Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions. Clin Infect Dis 1995;21:188-93.